Literature DB >> 18164828

Assessment of extended-field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy.

Jidong Lian1, Marc Mackenzie, Kurian Joseph, Nadeem Pervez, George Dundas, Raul Urtasun, Robert Pearcey.   

Abstract

PURPOSE: To perform a dosimetric comparison of three-dimensional conformal radiotherapy (3D-CRT), intensity-modulated radiotherapy (IMRT), and helical tomotherapy (HT) plans for pelvic and para-aortic RT in postoperative endometrial cancer patients; and to evaluate the integral dose (ID) received by critical structures within the radiation fields. METHODS AND MATERIALS: We selected 10 patients with Stage IIIC endometrial cancer. For each patient, three plans were created with 3D-CRT, IMRT, and HT. The IMRT and HT plans were both optimized to keep the mean dose to the planning target volume (PTV) the same as that with 3D-CRT. The dosimetry and ID for the critical structures were compared. A paired two-tailed Student t test was used for data analysis.
RESULTS: Compared with the 3D-CRT plans, the IMRT plans resulted in lower IDs in the organs at risk (OARs), ranging from -3.49% to -17.59%. The HT plans showed a similar result except that the ID for the bowel increased 0.27%. The IMRT and HT plans both increased the IDs to normal tissue (see Table 1 and text for definition), pelvic bone, and spine (range, 3.31-19.7%). The IMRT and HT dosimetry showed superior PTV coverage and better OAR sparing than the 3D-CRT dosimetry. Compared directly with IMRT, HT showed similar PTV coverage, lower Ids, and a decreased dose to most OARs.
CONCLUSION: Intensity-modulated RT and HT appear to achieve excellent PTV coverage and better sparing of OARs, but at the expense of increased IDs to normal tissue and skeleton. HT allows for additional improvement in dosimetry and sparing of most OARs.

Entities:  

Mesh:

Year:  2007        PMID: 18164828     DOI: 10.1016/j.ijrobp.2007.10.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Vaginal displacement during course of adjuvant radiation for cervical cancer: results from a prospective IG-IMRT study.

Authors:  S Chopra; A Patidar; T Dora; N Moirangthem; S N Paul; R Engineer; U Mahantshetty; S K Shrivastava
Journal:  Br J Radiol       Date:  2014-08-19       Impact factor: 3.039

2.  Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques.

Authors:  A Rabinovich; L Bernard; A V Ramanakumar; G Stroian; W H Gotlieb; S Lau; B Bahoric
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

3.  Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity.

Authors:  Simone Marnitz; Carmen Stromberger; Michael Kawgan-Kagan; Waldemar Wlodarczyk; Ulrich Jahn; Achim Schneider; Uwe Ulrich; Volker Budach; Christhardt Köhler
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

4.  Dosimetric Comparison of Pencil-Beam Scanning and Photon-Based Radiation Therapy as a Boost in Carcinoma of Cervix.

Authors:  Manoj K Sharma; Eugen B Hug; Manindra Bhushan; Dennis Mah; Dominic Maes; Munish Gairola; Surender K Sharma; Girigesh Yadav; Manoj Pal; Deepika Chauhan; Abhinav Dewan; Inderjit Kaur; Sarthak Tandon; Swarupa Mitra
Journal:  Int J Part Ther       Date:  2017-12-28

5.  Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma.

Authors:  Chen-Hsi Hsieh; Pei-Wei Shueng; Sheng-Mou Hsiao; Ming-Chow Wei; Wen-Yih Wu; Hsu-Dong Sun; Hui-Ju Tien; Li-Ying Wang; Yen-Ping Hsieh
Journal:  Onco Targets Ther       Date:  2012-10-01       Impact factor: 4.147

6.  Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation.

Authors:  Dandan Wang; Yueju Yin; Qichao Zhou; Zirong Li; Xingmin Ma; Yong Yin; Baosheng Li; Tong Bai; Dapeng Li; Jian Zhu
Journal:  Med Phys       Date:  2021-12-10       Impact factor: 4.506

7.  Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities.

Authors:  Rosanna Yeung; Yarrow McConnell; Heather Warkentin; Darren Graham; Brad Warkentin; Kurian Joseph; Corinne M Doll
Journal:  Radiat Oncol       Date:  2015-04-17       Impact factor: 3.481

8.  SmartArc-based volumetric modulated arc therapy for endometrial cancer: a dosimetric comparison with helical tomotherapy and intensity-modulated radiation therapy.

Authors:  Ruijie Yang; Junjie Wang; Shouping Xu; Hua Li
Journal:  BMC Cancer       Date:  2013-11-01       Impact factor: 4.430

9.  Integral dose and radiation-induced secondary malignancies: comparison between stereotactic body radiation therapy and three-dimensional conformal radiotherapy.

Authors:  Marco D'Arienzo; Stefano G Masciullo; Vitaliana de Sanctis; Mattia F Osti; Laura Chiacchiararelli; Riccardo M Enrici
Journal:  Int J Environ Res Public Health       Date:  2012-11-19       Impact factor: 3.390

10.  Dose to organs at risk in the upper abdomen in patients treated with extended fields by helical tomotherapy: a dosimetric and clinical preliminary study.

Authors:  Sara Bresciani; Elisabetta Garibaldi; Gabriella Cattari; Angelo Maggio; Amalia Di Dia; Elena Delmastro; Domenico Gabriele; Michele Stasi; Pietro Gabriele
Journal:  Radiat Oncol       Date:  2013-10-25       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.